GlycoNAVI-Proteins is dataset of glycan and protein information. This is the content of GlycoNAVI.
Source | Last Updated |
---|---|
GlycoNAVI Proteins | September 04, 2024 |
PDB ID | UniProt ID ▲ | Title | Descriptor |
---|---|---|---|
8JYK | P0DTC2 | Structure of the SARS-CoV-2 XBB.1.5 spike glycoprotein (closed state 1) | |
8JYM | P0DTC2 | Structure of the SARS-CoV-2 XBB.1.5 spike glycoprotein (closed state 2) | |
8JYN | P0DTC2 | Structure of SARS-CoV-2 XBB.1.5 spike glycoprotein in complex with ACE2 (1-up state) | |
8JYO | P0DTC2 | Structure of SARS-CoV-2 XBB.1.5 spike glycoprotein in complex with ACE2 (2-up state) | |
8JYP | P0DTC2 | Structure of SARS-CoV-2 XBB.1.5 spike RBD in complex with ACE2 | |
8G73 | P0DTC2 | SARS-CoV-2 spike/Nb3 complex with 2 RBDs up and 3 Nb3 bound at 2.5 A | |
8G74 | P0DTC2 | SARS-CoV-2 spike/Nb3 complex with 1 RBD up and 2 Nb3 | |
8G75 | P0DTC2 | SARS-CoV-2 spike/Nb4 complex with 2 RBDs up and 3 Nb4 bound | |
8THF | P0DTC2 | SARS-CoV-2 BA.1 S-6P-no-RBD | |
6XE1 | P0DTC2 | Structure of SARS-CoV-2 spike protein receptor binding domain in complex with a potent neutralizing antibody, CV30 Fab | |
6XF5 | P0DTC2 | Cryo-EM structure of a biotinylated SARS-CoV-2 spike probe in the prefusion state (RBDs down) | Spike glycoprotein |
6XKL | P0DTC2 | SARS-CoV-2 HexaPro S One RBD up | Spike glycoprotein |
6ZP7 | P0DTC2 | SARS-CoV-2 spike in prefusion state (flexibility analysis, 1-up open conformation) | |
7AD1 | P0DTC2 | Cryo-EM structure of a prefusion stabilized SARS-CoV-2 Spike (D614N, R682S, R685G, A892P, A942P and V987P)(One up trimer) | Spike glycoprotein,Envelope glycoprotein,SARS-CoV-2 S protein |
7AD1 | P0DTC2 | Cryo-EM structure of a prefusion stabilized SARS-CoV-2 Spike (D614N, R682S, R685G, A892P, A942P and V987P)(One up trimer) | Spike glycoprotein,Envelope glycoprotein,SARS-CoV-2 S protein |
7B17 | P0DTC2 | SARS-CoV-spike RBD bound to two neutralising nanobodies. | |
7BEP | P0DTC2 | Crystal structure of the receptor binding domain of SARS-CoV-2 Spike glycoprotein in a ternary complex with COVOX-384 and S309 Fabs | |
7BZ5 | P0DTC2 | Structure of COVID-19 virus spike receptor-binding domain complexed with a neutralizing antibody | |
7CN9 | P0DTC2 | Cryo-EM structure of SARS-CoV-2 Spike ectodomain | Spike protein S1, Spike protein S2 |
7CZQ | P0DTC2 | S protein of SARS-CoV-2 in complex bound with P2B-1A10 | Spike glycoprotein, heavy chain of 4A8, light chain of 4A8 |
7CZU | P0DTC2 | S protein of SARS-CoV-2 in complex bound with P5A-1B6_2B | Spike glycoprotein, heavy chain of 4A8, light chain of 4A8 |
7D0D | P0DTC2 | S protein of SARS-CoV-2 in complex bound with P5A-3C12_2B | Spike glycoprotein, Light chain of Fab, Heavy chain of Fab |
7DX9 | P0DTC2 | Trypsin-digested S protein of SARS-CoV-2 bound with PD of ACE2 in the conformation 3 (3 up RBD and 2 PD bound) | Sodium-dependent neutral amino acid transporter B(0)AT1, Angiotensin-converting enzyme 2 (E.C.3.4.17.23) |
7EB5 | P0DTC2 | Cryo-EM structure of SARS-CoV-2 Spike D614G variant, two RBD-up conformation 2 | |
7EYA | P0DTC2 | Local CryoEM structure of the SARS-CoV-2 S6PV2 in complex with BD-804 Fab | |
7KDG | P0DTC2 | SARS-CoV-2 RBD down Spike Protein Trimer without the P986-P987 stabilizing mutations (S-GSAS) | Spike glycoprotein |
7KDK | P0DTC2 | SARS-CoV-2 D614G 3 RBD down Spike Protein Trimer without the P986-P987 stabilizing mutations (S-GSAS-D614G) | Spike glycoprotein |
7KE8 | P0DTC2 | SARS-CoV-2 D614G 3 RBD down Spike Protein Trimer without the P986-P987 stabilizing mutations (S-GSAS-D614G sub-classification) | |
7L2D | P0DTC2 | Cryo-EM structure of NTD-directed neutralizing antibody 1-87 in complex with prefusion SARS-CoV-2 spike glycoprotein | SARS-CoV-2 spike glycoprotein, 1-87 heavy chain, 1-87 light chain |
7LM8 | P0DTC2 | Crystal structure of SARS-CoV-2 spike protein receptor-binding domain in complex with two cross-neutralizing antibodies CV38-142 and COVA1-16 Fabs isolated from COVID-19 patients | |
7LXZ | P0DTC2 | SARS-CoV-2 S/S2M11/S2L28 Global Refinement | Spike glycoprotein, S2M11 Fab Light Chain variable region, S2M11 Fab Heavy Chain variable region, S2L28 Fab Heavy Chain variable region, S2L28 Fab Light Chain variable region |
7LY0 | P0DTC2 | SARS-CoV-2 S/S2M11/S2M28 Local Refinement | Spike glycoprotein, S2M28 Fab Light Chain variable region, S2M28 Fab Heavy Chain variable region |
7LYP | P0DTC2 | South African (B.1.351) SARS-CoV-2 spike protein variant (S-GSAS-B.1.351) in the 1-RBD-up conformation | |
7EKE | P0DTC2 | Structure of SARS-CoV-2 spike receptor-binding domain F486L mutation complexed with human ACE2 | |
7K9K | P0DTC2 | SARS-CoV-2 Spike RBD in complex with neutralizing Fab 2H04 (local refinement) | |
7MZF | P0DTC2 | SARS-CoV-2 receptor binding domain bound to Fab PDI 37 | |
7MZL | P0DTC2 | SARS-CoV-2 receptor binding domain bound to Fab PDI 210 | |
7SXW | P0DTC2 | Cryo-EM structure of the SARS-CoV-2 D614G,N501Y,E484K,K417T mutant spike protein ectodomain | |
7SXZ | P0DTC2 | Cryo-EM structure of the SARS-CoV-2 D614G,L452R mutant spike protein ectodomain bound to human ACE2 ectodomain (global refinement) | |
7V26 | P0DTC2 | XG005-bound SARS-CoV-2 S | |
7V2A | P0DTC2 | SARS-CoV-2 Spike trimer in complex with XG014 Fab | |
7V7R | P0DTC2 | Cryo-EM structure of SARS-CoV-2 S-Delta variant (B.1.617.2), one RBD-up conformation 4 | |
7V81 | P0DTC2 | Cryo-EM structure of SARS-CoV-2 S-Gamma variant (P.1) in complex with Angiotensin-converting enzyme 2 (ACE2) ectodomain, two ACE2-bound form | |
7Z0X | P0DTC2 | THSC20.HVTR26 Fab bound to SARS-CoV-2 Receptor Binding Domain | |
7Z0Y | P0DTC2 | THSC20.HVTR04 Fab bound to SARS-CoV-2 Receptor Binding Domain | |
7TEW | P0DTC2 | Cryo-EM structure of SARS-CoV-2 Delta (B.1.617.2) spike protein in complex with human ACE2 (focused refinement of RBD and ACE2) | |
7EJY | P0DTC2 | Complex Structure of antibody BD-503 and RBD of COVID-19 | |
7EJZ | P0DTC2 | Complex Structure of antibody BD-503 and RBD-S477N of COVID-19 | |
7FJO | P0DTC2 | Cryo-EM structure of South African (B.1.351) SARS-CoV-2 spike glycoprotein in complex with three T6 Fab | |
8WZI | P0DTC2 | One RBD up state of Spike glycoprotein, SARS-CoV-2 |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.0.0
Last updated: August 19, 2024